Compound information
- Natural Products
- ZC193983
- Molecular Formula
- C9H13NO2
- Molecular Weight
- 167.094628656 g/mol
- Structure
-
- IUPAC Name
- 1-pentylpyrrole-2,5-dione
- InChI
- InChI=1S/C9H13NO2/c1-2-3-4-7-10-8(11)5-6-9(10)12/h5-6H,2-4,7H2,1H3
- InChI Key
- CZUQOPAKOZMIPQ-UHFFFAOYSA-N
- SMILES
- CCCCCN1C(=O)C=CC1=O
- Source
- ZINC000002547519
Warheads
- Acrylamide
-
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 12 | Ring Count | 1 |
Heteroatom Count | 3 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 37.38 Å2 | LogP | 1.944 |
LogS | -2.714 | LogD | 1.227 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.184 | Pgp substrate | 0.005 |
HIA | 0.964 | F20 % | 0.949 |
F30 % | 0.284 | Caco-2 | -4.609 |
MDCK | -4.497 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.993 | PPB | 82.416 |
VD | 0.774 | Fu | 0.647 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.699 | CYP1A2 substrate | 0.581 |
CYP2A6 substrate | 0.565 | CYP2B6 substrate | 0.523 |
CYP2C19 inhibitor | 0.226 | CYP2C19 substrate | 0.431 |
CYP2C8 substrate | 0.506 | CYP2C9 inhibitor | 0.342 |
CYP2C9 substrate | 0.017 | CYP2D6 inhibitor | 0.02 |
CYP2D6 substrate | 0.085 | CYP2E1 substrate | 0.781 |
CYP3A4 inhibitor | 0.01 | CYP3A4 substrate | 0.237 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.724 | CL | 6.131 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.022 | Hepatotoxicity | 0.568 |
Mutagenicity | 0.003 | Rat Oral Acute Toxicity | 0.672 |
FDAMDD | 0.163 | Skin Sensitization | 0.976 |
Carcinogenicity | 0.429 | Eye Corrosion | 0.914 |
Eye Irritation | 0.981 | Respiratory Toxicity | 0.063 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.461 | IGC50 | 3.435 |
LC50FM | 3.233 | LC50DM | 3.705 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.1 | NR-AR-LBD | 0.238 |
NR-AhR | 0.005 | NR-Aromatase | 0.144 |
NR-ER | 0.21 | NR-ER-LBD | 0.375 |
NR-PPAR-gamma | 0.789 | SR-ARE | 0.862 |
SR-ATAD5 | 0.534 | SR-HSE | 0.895 |
SR-MMP | 0.158 | SR-p53 | 0.715 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.